A literature review on multimodality molecular imaging nanoprobes for cancer detection

[1] Hussain T, Nguyen QT. Molecular imaging for cancer diagnosis and surgery. Advanced Drug Delivery Reviews. 2014;66:90-100.10.1016/j.addr.2013.09.007446466024064465Search in Google Scholar

[2] Sun X, Li Y, Liu T, et al. Peptide-based imaging agents for cancer detection. Advanced Drug Delivery Reviews. 2017;110:38-51.10.1016/j.addr.2016.06.007523599427327937Search in Google Scholar

[3] Kircher MF, Hricak H, Larson SM. Molecular imaging for personalized cancer care. Molecular Oncology. 2012;6(2):182-195.10.1016/j.molonc.2012.02.005552837522469618Search in Google Scholar

[4] Khaniabadi PM, Shahbazi-Gahrouei D, Jaafar MS, et al. Magnetic iron oxide nanoparticles as T2 MR imaging contrast agent for detection of breast cancer (MCF-7) cell. Avicenna Journal of Medical Biotechnology. 2017;9(4):181-188.Search in Google Scholar

[5] Khaniabadi PM, Majid A, Asif M. et al. Breast cancer cell targeted MR molecular imaging probe: Anti-MUC1 antibody-based magnetic nanoparticles. Journal of Physics: Conference Series. 2017;851(1):012014.10.1088/1742-6596/851/1/012014Search in Google Scholar

[6] Mirzaei M, Mohagheghi M, Shahbazi-Gahrouei D. Synthesis and development of Gd3+-ALGDG2-C595 as MR Imaging Contrast Agent. Journal of Biomaterials and Nanobiotechnology. 2013;4(01):22.10.4236/jbnb.2013.41004Search in Google Scholar

[7] Khemthongcharoen N, Jolivot R, Rattanavarin S, Piyawattanametha W. Advances in imaging probes and optical microendoscopic imaging techniques for early in vivo cancer assessment. Advanced Drug Delivery Reviews. 2014;74:53-74.10.1016/j.addr.2013.09.01224120351Search in Google Scholar

[8] Savla R, Minko T. Nanoparticle design considerations for molecular imaging of apoptosis: Diagnostic, prognostic, and therapeutic value. Advanced Drug Delivery Reviews. 2017;113:122-140.10.1016/j.addr.2016.06.01627374457Search in Google Scholar

[9] Muthu MS, Leong DT, Mei L, Feng S-S. Nanotheranostics˗ application and further development of nanomedicine strategies for advanced theranostics. Theranostics. 2014;4(6):660-677.10.7150/thno.8698398213524723986Search in Google Scholar

[10] Guo R, Lu G, Qin B, Fei B. Ultrasound Imaging Technologies for Breast Cancer Detection and Management: A Review. Ultrasound in Medicine and Biology. 2018;44(1):37-70.10.1016/j.ultrasmedbio.2017.09.012616999729107353Search in Google Scholar

[11] Li N, Han L, Jing H. Contrast-enhanced ultrasound with a novel nanoparticle contrast agent for clinical diagnosis in patients with non-small cell lung cancer. Experimental and Therapeutic Medicine. 2017;14(4):3768-3773.10.3892/etm.2017.4933563931229042977Search in Google Scholar

[12] Paefgen V, Doleschel D, Kiessling F. Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Frontiers in Pharmacology. 2015;6:197.10.3389/fphar.2015.00197458493926441654Search in Google Scholar

[13] Beik J, Shiran MB, Abed Z, et al. Gold nanoparticle-induced sonosensitization enhances the antitumor activity of ultrasound in colon tumor-bearing mice. Medical Physics. 2018;45(9):4306-4314.10.1002/mp.1310030043986Search in Google Scholar

[14] Milgroom A, Intrator M, Madhavan K, et al. Mesoporous silica nanoparticles as a breast-cancer targeting ultrasound contrast agent. Colloids and Surfaces B, Biointerfaces. 2014;116:652-657.10.1016/j.colsurfb.2013.10.038468740824269054Search in Google Scholar

[15] Martins SF, Garcia EA, Luz MA, et al. Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer. Cancer Genomics & Proteomics. 2013;10(2):55-67.Search in Google Scholar

[16] Abou-Elkacem L, Wilson KE, Johnson SM, et al. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent. Theranostics. 2016;6(11):1740-1752.10.7150/thno.15169499723327570547Search in Google Scholar

[17] Hao L, Wang Z, Luo J, et al. Preparation of targeted high molecular polymer microbubble encapsuling quantum dots and cell experiment study in vitro. Journal of Chongqing Medical University. 2013(1):24-27.10.1097/SCS.0b013e31828010eb23524706Search in Google Scholar

[18] Lutz AM, Bachawal SV, Drescher CW, et al. Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model. Clinical Cancer Research. 2014;20(5):1313-1322.10.1158/1078-0432.CCR-13-1642396529324389327Search in Google Scholar

[19] Yoon YI, Pang X, Jung S, et al. Smart gold nanoparticle-stabilized ultrasound microbubbles as cancer theranostics. Journal of Materials Chemistry B. 2018;6(20):3235-3239.10.1039/C8TB00368H622610130420913Search in Google Scholar

[20] Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev. 2008;60(10):1153-1166.10.1016/j.addr.2008.03.005272015918486268Search in Google Scholar

[21] Yildirim A, Shi D, Roy S, et al. Nanoparticle-Mediated Acoustic Cavitation Enables High Intensity Focused Ultrasound Ablation Without Tissue Heating. ACS Applied Materials & Interfaces. 2018;10(43):36786-36795.10.1021/acsami.8b15368670212830339360Search in Google Scholar

[22] McLaughlan J, Cowell D, Freear S. Gold nanoparticle nucleated cavitation for enhanced high intensity focused ultrasound therapy. Physics in Medicine & Biology. 2017;63(1):015004.10.1088/1361-6560/aa97e929098986Search in Google Scholar

[23] Nedaei TS, Delavari HH. Preparation of Naturally Active Melanin Nano-Platforms Chelated with Barium Ions as a Potential X-Ray-Computed Tomography Contrast Agent. ChemistrySelect. 2018;3(39):11098-11102.10.1002/slct.201801305Search in Google Scholar

[24] Wallyn J, Anton N, Serra CA, et al. A new formulation of poly (MAOTIB) nanoparticles as an efficient contrast agent for in vivo X-ray imaging. Acta Biomaterialia. 2018;66:200-212.10.1016/j.actbio.2017.11.01129129788Search in Google Scholar

[25] Hainfeld JF, Ridwan SM, Stanishevskiy Y, et al. Small, Long Blood Half-Life Iodine Nanoparticle for Vascular and Tumor Imaging. Scientific Reports. 2018;8(1):13803.10.1038/s41598-018-31940-2613867330218059Search in Google Scholar

[26] Goldman LW. Principles of CT and CT technology. J Nucl Med Technol. 2007;35(3):115-28; quiz 29-30.10.2967/jnmt.107.04297817823453Search in Google Scholar

[27] Kim D, Yu MK, Lee TS, et al. Amphiphilic polymer-coated hybrid nanoparticles as CT/MRI dual contrast agents. Nanotechnology. 2011;22(15):155101.10.1088/0957-4484/22/15/15510121389582Search in Google Scholar

[28] Gu X, Liu R. Application of 18F-FDG PET/CT combined with carbohydrate antigen 19-9 for differentiating pancreatic carcinoma from chronic mass-forming pancreatitis in Chinese elderly. Clin Interv Aging. 2016;11:1365-1370.10.2147/CIA.S115254504772127729779Search in Google Scholar

[29] Zheng X, Wang S, Wu L, Hou X. Microwave-assisted facile synthesis of mono-dispersed Ba/Ho co-doped nanohydroxyapatite for potential application as binary CT imaging contrast agent. Microchemical Journal. 2018;141:330-336.10.1016/j.microc.2018.05.044Search in Google Scholar

[30] Naha PC, Lau KC, Hsu JC, et al. Gold silver alloy nanoparticles (GSAN): an imaging probe for breast cancer screening with dual-energy mammography or computed tomography. Nanoscale. 2016;8(28):13740-13754.10.1039/C6NR02618D495556527412458Search in Google Scholar

[31] Shi X, Wang SH, Van Antwerp ME, et al. Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticles. The Analyst. 2009;134(7):1373-1379.10.1039/b902199j291722419562204Search in Google Scholar

[32] Eck W, Nicholson AI, Zentgraf H, et al. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Letters. 2010;10(7):2318-2322.10.1021/nl101019s20496900Search in Google Scholar

[33] Zhang Z, Ross RD, Roeder RK. Preparation of functionalized gold nanoparticles as a targeted X-ray contrast agent for damaged bone tissue. Nanoscale. 2010;2(4):582-586.10.1039/b9nr00317g20644762Search in Google Scholar

[34] Aydogan B, Li J, Rajh T, et al. AuNP-DG: Deoxyglucose-labeled gold nanoparticles as X-ray computed tomography contrast agents for cancer imaging. Molecular Imaging and Biology. 2010;12(5):463-467.10.1007/s11307-010-0299-820237857Search in Google Scholar

[35] Zhou B, Yang J, Peng C, et al. PEGylated polyethylenimine-entrapped gold nanoparticles modified with folic acid for targeted tumor CT imaging. Colloids and surfaces B, Biointerfaces. 2016;140:489-496.10.1016/j.colsurfb.2016.01.01926812636Search in Google Scholar

[36] Khademi S, Sarkar S, Shakeri-Zadeh A, et al. Folic acid-cysteamine modified gold nanoparticle as a nanoprobe for targeted computed tomography imaging of cancer cells. Materials Science and Engineering: C. 2018;89:182-193.10.1016/j.msec.2018.03.01529752088Search in Google Scholar

[37] Zhang Y, Wen S, Zhao L, et al. Ultrastable polyethyleneimine-stabilized gold nanoparticles modified with polyethylene glycol for blood pool, lymph node and tumor CT imaging. Nanoscale. 2016;8(10):5567-5577.10.1039/C5NR07955ASearch in Google Scholar

[38] Nakagawa T, Gonda K, Kamei T, et al. X-ray computed tomography imaging of a tumor with high sensitivity using gold nanoparticles conjugated to a cancer-specific antibody via polyethylene glycol chains on their surface. Science and Technology of Advanced Materials. 2016;17(1):387-297.10.1080/14686996.2016.1194167510186427877890Search in Google Scholar

[39] Kobayashi Y, Shibuya K, Tokunaga M, et al. Preparation of high-concentration colloidal solution of silica-coated gold nanoparticles and their application to X-ray imaging. Journal of Sol-Gel Science and Technology. 2016;78(1):82-90.10.1007/s10971-015-3921-zSearch in Google Scholar

[40] Cole LE, Ross RD, Tilley JM, et al. Gold nanoparticles as contrast agents in X-ray imaging and computed tomography. Nanomedicine. 2015;10(2):321-341.10.2217/nnm.14.17125600973Search in Google Scholar

[41] Jing L, Liang X, Deng Z, et al. Prussian blue coated gold nanoparticles for simultaneous photoacoustic/CT bimodal imaging and photothermal ablation of cancer. Biomaterials. 2014;35(22):5814-5821.10.1016/j.biomaterials.2014.04.00524746962Search in Google Scholar

[42] Zhang J, Li C, Zhang X, et al. In vivo tumor-targeted dual-modal fluorescence/CT imaging using a nanoprobe co-loaded with an aggregation-induced emission dye and gold nanoparticles. Biomaterials. 2015;42:103-111.10.1016/j.biomaterials.2014.11.05325542798Search in Google Scholar

[43] Bi H, He F, Dong Y, et al. Bismuth Nanoparticles with “Light” Property Served as a Multifunctional Probe for X-ray Computed Tomography and Fluorescence Imaging. Chemistry of Materials. 2018;30(10):3301-3307.10.1021/acs.chemmater.8b00565Search in Google Scholar

[44] Fazel-Ghaziyani M, Shahbazi-Gahrouei D, Pourhassan-Moghaddam M, et al. Targeted detection of the cancer cells using the anti-CD24 bio modified PEGylated gold nanoparticles: the application of CD24 as a vital cancer biomarker. Nanomedicine J. 2018;5(3):172-179.Search in Google Scholar

[45] Tang D, Gao W, Yuan Y, et al. Novel Biocompatible Au Nanostars@PEG Nanoparticles for In Vivo CT Imaging and Renal Clearance Properties. Nanoscale Research Letters. 2017;12(1):565.10.1186/s11671-017-2332-1563980429027145Search in Google Scholar

[46] Yu N, Wang Z, Zhang J, et al. Thiol-capped Bi nanoparticles as stable and all-in-one type theranostic nanoagents for tumor imaging and thermoradiotherapy. Biomaterials. 2018;161:279-291.10.1016/j.biomaterials.2018.01.04729425848Search in Google Scholar

[47] Wu B, Lu S-T, Yu H, et al. Gadolinium-chelate functionalized bismuth nanotheranostic agent for in vivo MRI/CT/PAI imaging-guided photothermal cancer therapy. Biomaterials. 2018;159:37-47.10.1016/j.biomaterials.2017.12.02229309992Search in Google Scholar

[48] Wang Y, Cai D, Wu H, et al. Functionalized Cu 3 BiS 3 nanoparticles for dual-modal imaging and targeted photothermal/photodynamic therapy. Nanoscale. 2018;10(9):4452-1162.10.1039/C7NR07458ASearch in Google Scholar

[49] Kaufmann PA, Di Carli MF, editors. Hybrid SPECT/CT and PET/CT imaging: the next step in noninvasive cardiac imaging. Seminars in nuclear medicine; 2009: Elsevier.10.1053/j.semnuclmed.2009.03.00719646558Search in Google Scholar

[50] Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging? European Journal of Nuclear Medicine and Molecular Imaging. 2009;36(Suppl1):113-120.10.1007/s00259-008-0951-619104802Search in Google Scholar

[51] Giovacchini G, Picchio M, Garcia-Parra R, et al. 11C-choline PET/CT predicts prostate cancer–specific survival in patients with biochemical failure during androgen-deprivation therapy. Journal of Nuclear Medicine. 2014;55(2):233-241.10.2967/jnumed.113.12338024408897Search in Google Scholar

[52] Takenaka D, Ohno Y, Koyama H, et al. Integrated FDG-PET/CT vs. standard radiological examinations: comparison of capability for assessment of postoperative recurrence in non-small cell lung cancer patients. European Journal of Radiology. 2010;74(3):458-464.10.1016/j.ejrad.2009.03.00719398291Search in Google Scholar

[53] Buck AK, Herrmann K, Stargardt T, et al. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches. Journal of Nuclear Medicine Technology. 2010;38(1):6-17.10.2967/jnmt.108.05958420197541Search in Google Scholar

[54] Miyazaki T, Sohda M, Higuchi T, et al. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer. Anticancer Research. 2014;34(1):283-287.Search in Google Scholar

[55] Khan N, Oriuchi N, Higuchi T, et al. PET in the follow-up of differentiated thyroid cancer. British Journal of Radiology. 2003;76(910):690-695.10.1259/bjr/3153833114512328Search in Google Scholar

[56] Skovgaard D, Persson M, Brandt-Larsen M, et al. Safety, dosimetry, and tumor detection ability of 68Ga-NOTA-AE105: First-inhuman study of a novel radioligand for uPAR PET imaging. Journal of Nuclear Medicine. 2017;58(3):379-386.10.2967/jnumed.116.17897027609788Search in Google Scholar

[57] McDonagh PR, Sundaresan G, Yang L, et al. Biodistribution and PET imaging of 89-zirconium labeled cerium oxide nanoparticles synthesized with several surface coatings. Nanomedicine: Nanotechnology, Biology and Medicine. 2018;14(4):1429-1440.10.1016/j.nano.2018.04.002617566529641981Search in Google Scholar

[58] Berke S, Kampmann A-L, Wuest M, et al. 18F-Radiolabeling and In Vivo Analysis of SiFA-Derivatized Polymeric Core–Shell Nanoparticles. Bioconjugate Chemistry. 2017;29(1):89-95.10.1021/acs.bioconjchem.7b0063029202229Search in Google Scholar

[59] Rowe SP, Gage KL, Faraj SF, et al. 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer. Journal of Nuclear Medicine. 2015;56(7):1003-1010.10.2967/jnumed.115.154336465940026069305Search in Google Scholar

[60] Rainone P, Riva B, Belloli S, et al. Development of 99mTc-radiolabeled nanosilica for targeted detection of her2-positive breast cancer. International Journal of Nanomedicine. 2017;12:3447-3461.10.2147/IJN.S129720542233028496321Search in Google Scholar

[61] Polyak A, Nagy LN, Mihaly J, et al. Preparation and 68Ga-radiolabeling of porous zirconia nanoparticle platform for PET/CT-imaging guided drug delivery. Journal of Pharmaceutical and Biomedical Analysis. 2017;137:146-150.10.1016/j.jpba.2017.01.02828119212Search in Google Scholar

[62] Pascual L, Cerqueira-Coutinho C, García-Fernández A, et al. MUC1 aptamer-capped mesoporous silica nanoparticles for controlled drug delivery and radio-imaging applications. Nanomedicine: Nanotechnology, Biology and Medicine. 2017;13(8):2495-2505.10.1016/j.nano.2017.08.00628842375Search in Google Scholar

[63] Norregaard K, Jørgensen JT, Simón M, et al. 18F-FDG PET/CT-based early treatment response evaluation of nanoparticle-assisted photothermal cancer therapy. PloS one. 2017;12(5):e0177997.10.1371/journal.pone.0177997544352828542311Search in Google Scholar

[64] Cassidy PJ, Radda GK. Molecular imaging perspectives. Journal of the Royal Society Interface. 2005;2(3):133-144.10.1098/rsif.2005.0040162907316849174Search in Google Scholar

[65] Szigeti K, Hegedűs N, Rácz K, et al. Thallium Labeled Citrate-Coated Prussian Blue Nanoparticles as Potential Imaging Agent. Contrast Media and Molecular Imaging. 2018;2018:2023604.10.1155/2018/2023604594420529853803Search in Google Scholar

[66] de Souza Albernaz M, Toma SH, Clanton J, et al. Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging. Pharmaceutical Research. 2018;35(1):24.10.1007/s11095-017-2320-229305666Search in Google Scholar

[67] Thomas R, Park I-K, Jeong Y. Magnetic iron oxide nanoparticles for multimodal imaging and therapy of cancer. International Journal of Molecular Sciences. 2013;14(8):15910-15930.10.3390/ijms140815910375989323912234Search in Google Scholar

[68] Misri R, Meier D, Yung AC, et al. Development and evaluation of a dual-modality (MRI/SPECT) molecular imaging bioprobe. Nanomedicine: Nanotechnology, Biology and Medicine. 2012;8(6):1007-1016.10.1016/j.nano.2011.10.01322100757Search in Google Scholar

[69] Pham TN, Lengkeek NA, Greguric I, et al. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles. International Journal of Nanomedicine. 2017;12:899-909.10.2147/IJN.S127171529132628184160Search in Google Scholar

[70] Bennett KM, Jo J, Cabral H, et al. MR imaging techniques for nano-pathophysiology and theranostics. Advanced Drug Delivery Reviews. 2014;74:75-94.10.1016/j.addr.2014.04.00724787226Search in Google Scholar

[71] Shahbazi-Gahrouei D. Novel MR imaging contrast agents for cancer detection. Journal of Research in Medical Sciences. 2009;14(3):141-147.Search in Google Scholar

[72] Lauterbur P. Image-formation by induced local interactions-examples employing nuclear magnetic-resonance. Clinical Orthopaedics and Related Research. 1989;244:3-6.10.1097/00003086-198907000-00002Search in Google Scholar

[73] Shahbazi-Gahrouei D, Williams M, Rizvi S, Allen B. In vivo studies of Gd-DTPA-monoclonal antibody and gd-porphyrins: Potential magnetic resonance imaging contrast agents for melanoma. Journal of Magnetic Resonance Imaging. 2001;14(2):169-174.10.1002/jmri.116811477676Search in Google Scholar

[74] Shahbazi-Gahrouei D, Rizvi S, Williams M, Allen B. In vitro studies of gadolinium-DTPA conjugated with monoclonal antibodies as cancer-specific magnetic resonance imaging contrast agents. Australasian Physics and Engineering Sciences in Medicine. 2002;25(1):31-38.10.1007/BF0317837212049473Search in Google Scholar

[75] Mirzaei M, Mohagheghi M, Shahbazi-Gahrouei D, Khatami A. Gd3+-Anionic Linear Globular Dendrimer-G2-C595 A Dual Novel Nanoprobe for MR Imaging and Therapeutic Agent. J Nanomed Nanotechnol. 2012;3(7):1000147.10.4172/2157-7439.1000147Search in Google Scholar

[76] Zhang M, Cao Y, Chong Y, et al. Graphene oxide based theranostic platform for T 1-weighted magnetic resonance imaging and drug delivery. ACS Applied Materials and Interfaces. 2013;5(24):13325-13332.10.1021/am404292e24313343Search in Google Scholar

[77] Shahbazi-Gahrouei D, Abdolahi M. A novel method for quantitative analysis of anti-MUC1 expressing ovarian cancer cell surface based on magnetic cell separation. Journal of Medical Sciences. 2012;12(8):256-266.10.3923/jms.2012.256.266Search in Google Scholar

[78] Abdolahi M, Shahbazi-Gahrouei D, Laurent S, et al. Synthesis and in vitro evaluation of MR molecular imaging probes using J591 mAb-conjugated SPIONs for specific detection of prostate cancer. Contrast Media and Molecular Imaging. 2013;8(2):175-184.10.1002/cmmi.151423281290Search in Google Scholar

[79] Shahbazi-Gahrouei D, Abdolahi M. Detection of MUC1-expressing ovarian cancer by C595 monoclonal antibody-conjugated SPIONs using MR imaging. The Scientific World Journal. 2013;2013:609151.10.1155/2013/609151380649024194685Search in Google Scholar

[80] Shahbazi-Gahrouei D, Abdolahi M. Superparamagnetic iron oxide-C595: Potential MR imaging contrast agents for ovarian cancer detection. Journal of Medical Physics. 2013;38(4):198-204.10.4103/0971-6203.121198395900024672155Search in Google Scholar

[81] Shahbazi-Gahrouei D, Khodamoradi E. Porphyrin-based agents: potential MR imaging contrast agents for colorectal (HT29/219) detection in mice. Journal of Medical Sciences. 2007;7(6):1015-1020.10.3923/jms.2007.1015.1020Search in Google Scholar

[82] Fang H, Liu C, Liu C, et al. Gd-DTPA-dialkylamine derivatives: Synthesis and self-assembled behaviors for T1-enhanced magnetic resonance imaging and drug carriers. Journal of Molecular Liquids. 2018;268:77-86.10.1016/j.molliq.2018.07.004Search in Google Scholar

[83] Keshtkar M, Shahbazi-Gahrouei D, Mehrgardi M, Aghaei M. Synthesis and Cytotoxicity Assessment of Gold-coated Magnetic Iron Oxide Nanoparticles. Journal of Biomedical Physics and Engineering. 2018;8(4):357-364.Search in Google Scholar

[84] Keshtkar M, Shahbazi-Gahrouei D, Khoshfetrat SM, et al. Aptamer-conjugated magnetic nanoparticles as targeted magnetic resonance imaging contrast agent for breast cancer. Journal of Medical Signals and Sensors. 2016;6(4):243-247.10.4103/2228-7477.195093Search in Google Scholar

[85] Ghahremani F, Shahbazi-Gahrouei D, Kefayat A, et al. AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Advances. 2018;8(8):4249-4258.10.1039/C7RA11116ASearch in Google Scholar

[86] Ghahremani F, Kefayat A, Shahbazi-Gahrouei D, Motaghi H, Mehrgardi MA, Javanmard SH. AS1411 Aptamer targeted gold nanoclusters effect on enhancement of radiation therapy efficacy in 4T1 breast tumor-bearing mice. Nanomedicine. 2018; 13(20): 2563-2578.10.2217/nnm-2018-018030334677Search in Google Scholar

[87] Li J, Wu C, Hou P, et al. One-pot preparation of hydrophilic manganese oxide nanoparticles as T1 nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo. Biosensors and Bioelectronics. 2018;102:1-8.10.1016/j.bios.2017.10.04729101783Search in Google Scholar

[88] Liu K, Yan X, Xu Y-J, et al. Sequential growth of CaF 2: Yb, Er@ CaF 2: Gd nanoparticles for efficient magnetic resonance angiography and tumor diagnosis. Biomaterials Science. 2017;5(12):2403-2415.10.1039/C7BM00797CSearch in Google Scholar

[89] Ma L, Liu Y, Liu Liu L, et al. Simultaneous activation of short-wave infrared (SWIR) light and paramagnetism by a functionalized shell for high penetration and spatial resolution theranostics. Advanced Functional Materials. 2018;28(6):1705057.10.1002/adfm.201705057Search in Google Scholar

[90] You Q, Sun Q, Yu M, et al. BSA–Bioinspired Gadolinium Hybrid-Functionalized Hollow Gold Nanoshells for NIRF/PA/CT/MR Quadmodal Diagnostic Imaging-Guided Photothermal/Photodynamic Cancer Therapy. ACS Applied Materials & Interfaces. 2017;9(46):40017-40030.10.1021/acsami.7b1192629087183Search in Google Scholar

[91] Payne WM, Hill TK, Svechkarev D, et al. Multimodal imaging nanoparticles derived from hyaluronic acid for integrated preoperative and intraoperative cancer imaging. Contrast Media and Molecular Imaging. 2017;2017:9616791.10.1155/2017/9616791561269829097944Search in Google Scholar

[92] Chan WC, Nie S. Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science. 1998;281(5385):2016-2018.10.1126/science.281.5385.20169748158Search in Google Scholar

[93] Chen H, Wang Y, Wang T, et al. Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor. Journal of Nanobiotechnology. 2016;14(1):52.10.1186/s12951-016-0195-8491802927339420Search in Google Scholar

[94] Srinivas M, Heerschap A, Ahrens ET, et al. 19F MRI for quantitative in vivo cell tracking. Trends in Biotechnology. 2010;28(7):363-370.10.1016/j.tibtech.2010.04.002290264620427096Search in Google Scholar

[95] Xu M, Guo C, Hu G, et al. Organic Nanoprobes for Fluorescence and 19F Magnetic Resonance Dual-Modality Imaging. Chinese Journal of Chemistry. 2018;36(1):25-30.10.1002/cjoc.201700382Search in Google Scholar

[96] Depalo N, Corricelli M, De Paola I, et al. NIR Emitting Nanoprobes Based on Cyclic RGD Motif Conjugated PbS Quantum Dots for Integrin-Targeted Optical Bioimaging. ACS Appl Mater Interfaces. 2017;9(49):43113-43126.10.1021/acsami.7b1415529148709Search in Google Scholar

[97] Xie W, Wang L, Zhang Y, et al. Nuclear targeted nanoprobe for single living cell detection by surface-enhanced Raman scattering. Bioconjug Chem. 2009;20(4):768-773.10.1021/bc800469g19267459Search in Google Scholar

[98] Repenko T, Rix A, Nedilko A, et al. Strong photoacoustic signal enhancement by coating gold nanoparticles with melanin for biomedical imaging. Advanced Functional Materials. 2018;28(7):1705607.10.1002/adfm.201705607Search in Google Scholar

[99] Liu Y, Lv X, Liu H, et al. Porous gold nanocluster-decorated manganese monoxide nanocomposites for microenvironmentactivatable MR/photoacoustic/CT tumor imaging. Nanoscale. 2018;10(8):3631-3638.10.1039/C7NR08535DSearch in Google Scholar

[100] Zhang L, Wang D, Yang K, et al. Mitochondria-Targeted Artificial “Nano-RBCs” for Amplified Synergistic Cancer Phototherapy by a Single NIR Irradiation. Advanced Science. 2018;5(5):1800049.10.1002/advs.201800049609714330128231Search in Google Scholar

[101] Pansare V, Hejazi S, Faenza W, Prud’homme RK. Review of Long-Wavelength Optical and NIR Imaging Materials: Contrast Agents, Fluorophores and Multifunctional Nano Carriers. Chemistry of Materials. 2012;24(5):812-827.10.1021/cm2028367342322622919122Search in Google Scholar

[102] Ren F, Ding L, Liu H, et al. Ultra-small nanocluster mediated synthesis of Nd3+-doped core-shell nanocrystals with emission in the second near-infrared window for multimodal imaging of tumor vasculature. Biomaterials. 2018;175:30-43.10.1016/j.biomaterials.2018.05.02129800756Search in Google Scholar

[103] Pisanic TR 2nd, Zhang Y, Wang TH. Quantum dots in diagnostics and detection: principles and paradigms. The Analyst. 2014;139(12):2968-2981.10.1039/C4AN00294F409665324770716Search in Google Scholar

[104] Liu H, Li Z, Sun Y, et al. Synthesis of Luminescent Carbon Dots with Ultrahigh Quantum Yield and Inherent Folate Receptor-Positive Cancer Cell Targetability. Scientific Reports. 2018;8(1):1086.10.1038/s41598-018-19373-3577369229348413Search in Google Scholar

[105] Pellerin M, Glais E, Lecuyer T, et al. LaAlO₃: Cr³⁺, Sm³⁺: Nano-perovskite with persistent luminescence for in vivo optical imaging. Journal of Luminescence. 2018;202:83-88.10.1016/j.jlumin.2018.05.024Search in Google Scholar

[106] Schroeder KL, Goreham RV, Nann T. Graphene Quantum Dots for Theranostics and Bioimaging. Pharm Res. 2016;33(10):2337-2357.10.1007/s11095-016-1937-x27207272Search in Google Scholar

[107] Hai X, Guo Z, Lin X, et al. Fluorescent TPA@GQDs Probe for Sensitive Assay and Quantitative Imaging of Hydroxyl Radicals in Living Cells. ACS Appl Mater Interfaces. 2018;10(6):5853-5861.10.1021/acsami.7b1609429350900Search in Google Scholar